Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (6470)
All Articles published online
|
Publishing Process of This Article
|
Sep 28, 2019 (publication date) through Apr 16, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wang Q, Chen Q, Zhang X, Lu XL, Du Q, Zhu T, Zhang GY, Wang DS, Fan QM. Diagnostic value of gamma-glutamyltransferase/aspartate aminotransferase ratio, protein induced by vitamin K absence or antagonist II, and alpha-fetoprotein in hepatitis B virus-related hepatocellular carcinoma. World J Gastroenterol 2019; 25(36): 5515-5529 [PMID: 31576097 DOI: 10.3748/wjg.v25.i36.5515] |
|---|---|
| URL: | https://www.wjgnet.com/1948-5182/full/v25/i36/5515.htm |
| Number | Citing Articles |
| 1 |
Libin Dong, Xun Qiu, Fengqiang Gao, Kai Wang, Xiao Xu. Protein induced by vitamin K absence or antagonist II: Experience to date and future directions. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer 2023; 1878(6): 189016 doi: 10.1016/j.bbcan.2023.189016
|
| 2 |
Lin Sun, Meixiu Gu, Jiabin Cai, Wenjing Yang, Baishen Pan, Beili Wang, Chunyan Zhang, Wei Guo. Combining γ‐GT, PIVKA‐II, and AFP to predict long‐term prognosis in patients with hepatocellular carcinoma after hepatectomy. Clinical and Experimental Pharmacology and Physiology 2023; 50(4): 287 doi: 10.1111/1440-1681.13745
|
| 3 |
Mingjun Liu, Zhou Zhang, Wei Zhang, Song‐Mei Liu. Advances in biomarker discovery using circulating cell‐free DNA for early detection of hepatocellular carcinoma. WIREs Mechanisms of Disease 2023; 15(3) doi: 10.1002/wsbm.1598
|
| 4 |
Masahisa Ohtsuka, Kazuya Iwamoto, Atsushi Naito, Mitsunobu Imasato, Satoshi Hyuga, Yujiro Nakahara, Manabu Mikamori, Kenta Furukawa, Jeongho Moon, Tadafumi Asaoka, Kentaro Kishi, Awad Shamma, Hiroki Akamatsu, Tsunekazu Mizushima, Hirofumi Yamamoto. Circulating MicroRNAs in Gastrointestinal Cancer. Cancers 2021; 13(13): 3348 doi: 10.3390/cancers13133348
|
| 5 |
Xu Zhang, Li-Na Wu, Xiao-Qing Li, Xia Luo, Shui-Wei Liu, Le Zhang, Shah Nawaz, Li-Na Ma, Xiang-Chun Ding. Whether the Golgi protein 73 could be a diagnostic serological marker in hepatocellular carcinoma: a meta analysis. BMC Gastroenterology 2023; 23(1) doi: 10.1186/s12876-023-02685-8
|
| 6 |
Qiao Ke, Fu Xiang, Chunhong Xiao, Qizhen Huang, Xiaolong Liu, Yongyi Zeng, Lei Wang, Jingfeng Liu. Exploring the clinical value of preoperative serum gamma-glutamyl transferase levels in the management of patients with hepatocellular carcinoma receiving postoperative adjuvant transarterial chemoembolization. BMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08843-z
|
| 7 |
Chutong He, Wanli Zhang, Yue Zhao, Jiamin Li, Ye Wang, Wang Yao, Nianhua Wang, Wenshuang Ding, Xinhua Wei, Ruimeng Yang, Xinqing Jiang. Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics: a retrospective study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1124069
|
| 8 |
Deyao Zhang, Huilan Zeng, Yangxun Pan, Yumo Zhao, Xin Wang, Jinbin Chen, Juncheng Wang, Yaojun Zhang, Zhongguo Zhou, Li Xu, Minshan Chen, Dandan Hu. Liver Tumor Markers, HALP Score, and NLR: Simple, Cost-Effective, Easily Accessible Indexes for Predicting Prognosis in ICC Patients after Surgery. Journal of Personalized Medicine 2022; 12(12): 2041 doi: 10.3390/jpm12122041
|
| 9 |
Mirela Georgiana Perne, Adela-Viviana Sitar-Tăut, Teodora Gabriela Alexescu, Lorena Ciumărnean, Mircea-Vasile Milaciu, Sorina-Cezara Coste, Calin-Vasile Vlad, Angela Cozma, Dan-Andrei Sitar-Tăut, Olga Hilda Orăşan, Alexandra Crăciun. Diagnostic Performance of Extrahepatic Protein Induced by Vitamin K Absence in the Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis. Diagnostics 2023; 13(5): 816 doi: 10.3390/diagnostics13050816
|
| 10 |
Xiangang Cao, Qian Yang, Qing Yu. Increased Expression of miR-487b Is Associated With Poor Prognosis and Tumor Progression of HBV-Related Hepatocellular Carcinoma. Open Forum Infectious Diseases 2020; 7(12) doi: 10.1093/ofid/ofaa498
|
| 11 |
Francisco Villalba-López, Luis Francisco Sáenz-Mateos, Maria Isabel Sánchez-Lorencio, Virginia De La Orden-García, Felipe Alconchel-Gago, Pedro Antonio Cascales-Campos, Carmen García-Bernardo, José Antonio Noguera-Velasco, Alberto Baroja-Mazo, Pablo Ramírez-Romero. Usefulness of PIVKA-II for monitoring after liver transplantation in patients with hepatocellular carcinoma. Scientific Reports 2023; 13(1) doi: 10.1038/s41598-023-32879-9
|
| 12 |
Agostino Colli, Tin Nadarevic, Damir Miletic, Vanja Giljaca, Mirella Fraquelli, Davor Štimac, Giovanni Casazza. Abdominal ultrasound and alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease. Cochrane Database of Systematic Reviews 2021; 2021(4) doi: 10.1002/14651858.CD013346.pub2
|
| 13 |
Nergis Ekmen, Çağri Akalin, Murat Akyildiz. Predictive value of protein induced by absence of vitamin K absence or antagonist II, alpha-fetoprotein and gamma-glutamyltransferase/aspartate aminotransferase ratio for the diagnosis of hepatocellular carcinoma in transplantation candidates. European Journal of Gastroenterology & Hepatology 2021; 32(2): 294 doi: 10.1097/MEG.0000000000001884
|
| 14 |
Bing-yao Pang, Yan Leng, Xiaoli Wang, Yi-qiang Wang, Li-hong Jiang. A meta-analysis and of clinical values of 11 blood biomarkers, such as AFP, DCP, and GP73 for diagnosis of hepatocellular carcinoma. Annals of Medicine 2023; 55(1): 42 doi: 10.1080/07853890.2022.2153163
|
| 15 |
Yong-Sheng Fang, Qiang Wu, Hong-Chuan Zhao, Yuan Zhou, Lei Ye, Sheng-Sheng Liu, Xiao-Xue Li, Wei-Dong Du. Do combined assays of serum AFP, AFP-L3, DCP, GP73, and DKK-1 efficiently improve the clinical values of biomarkers in decision-making for hepatocellular carcinoma? A meta-analysis. Expert Review of Gastroenterology & Hepatology 2021; 15(9): 1065 doi: 10.1080/17474124.2021.1900731
|
| 16 |
Expert consensus on the role of hematological markers in the early clinical screening of hepatocellular carcinoma. Liver Research 2022; 6(2): 66 doi: 10.1016/j.livres.2022.04.001
|
| 17 |
Jiang Li, Haisu Tao, Erlei Zhang, Zhiyong Huang. Diagnostic value of gamma‐glutamyl transpeptidase to alkaline phosphatase ratio combined with gamma‐glutamyl transpeptidase to aspartate aminotransferase ratio and alanine aminotransferase to aspartate aminotransferase ratio in alpha‐fetoprotein‐negative hepatocellular carcinoma. Cancer Medicine 2021; 10(14): 4844 doi: 10.1002/cam4.4057
|
| 18 |
Yan Lei, Xiaolan Lu, Xiuping Duan, Wei Tang, Qiang Wang. Bilirubin is a superior biomarker for hepatocellular carcinoma diagnosis and for differential diagnosis of benign liver disease. Journal of Laboratory Medicine 2023; 47(5): 233 doi: 10.1515/labmed-2023-0023
|
| 19 |
Qing-Qing Luo, Ting Wang, Kun-He Zhang. New indexes derived from routine blood tests and their clinical application in hepatocellular carcinoma. Clinics and Research in Hepatology and Gastroenterology 2022; 46(10): 102043 doi: 10.1016/j.clinre.2022.102043
|
| 20 |
Famei Qi, Aihua Zhou, Li Yan, Xiumei Yuan, Danni Wang, Ruoyun Chang, Yujun Zhang, Funa Shi, Xiaomei Han, Jinxia Hou, Lianhua Wei, Xu Zhang. The diagnostic value of PIVKA‐II, AFP, AFP‐L3, CEA, and their combinations in primary and metastatic hepatocellular carcinoma. Journal of Clinical Laboratory Analysis 2020; 34(5) doi: 10.1002/jcla.23158
|
| 21 |
Jianhao Yu, Zhenyu Wang, Zhiyang Jin. Progress and prospect of artificial intelligence in the diagnosis and treatment of liver cancer. Proceedings of the 2023 4th International Symposium on Artificial Intelligence for Medicine Science 2023; : 927 doi: 10.1145/3644116.3644275
|
| 22 |
Qi Zhang, Xingyuan Jiao, Osamah Ibrahim Khalaf. LDH and GGT/ALT Ratio as Novel Prognostic Biomarkers in Hepatocellular Carcinoma Patients after Liver Transplantation. Computational and Mathematical Methods in Medicine 2021; 2021: 1 doi: 10.1155/2021/9809990
|
| 23 |
Bo Li, Youyun Zhao, Wangxi Cai, Anping Ming, Hanmin Li. Validation and update of a multivariable prediction model for the identification and management of patients at risk for hepatocellular carcinoma. Clinical Proteomics 2021; 18(1) doi: 10.1186/s12014-021-09326-w
|
| 24 |
Jing-Yi Huang, Si-Yu Wang, Yong Lin, Huo-Chun Yi, Jian-Jun Niu. The Diagnostic Performance of lncRNAs from Blood Specimens in Patients with Hepatocellular Carcinoma: A Meta-Analysis. Laboratory Medicine 2021; 52(1): 64 doi: 10.1093/labmed/lmaa050
|
| 25 |
Fang Peng, Hao Yuan, Yi-Feng Zhou, Si-Xian Wu, Zhen-Yi Long, Ya-Meng Peng. Diagnostic Value of Combined Detection via Protein Induced by Vitamin K Absence or Antagonist II, Alpha-Fetoprotein, and D-Dimer in Hepatitis B Virus-Related Hepatocellular Carcinoma. International Journal of General Medicine 2022; : 5763 doi: 10.2147/IJGM.S362359
|
| 26 |
Ganbin Qiu, Jincan Chen, Weixiong Liao, Yonghui Liu, Zhongyan Wen, Yue Zhao. Gadoxetic acid-enhanced MRI combined with T1 mapping and clinical factors to predict Ki-67 expression of hepatocellular carcinoma. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1134646
|
| 27 |
Chenjun Huang, Xiao Xiao, Lin Tong, Zhiyuan Gao, Jun Ji, Lin Zhou, Ya Li, Lijuan Liu, Huijuan Feng, Meng Fang, Chunfang Gao. Risks and Clinical Predictors of Hepatocellular Carcinoma in Chinese Populations: A Real-World Study of 10,359 Patients in Six Medical Centers. Journal of Hepatocellular Carcinoma 2024; : 411 doi: 10.2147/JHC.S447700
|